Thanks to existing X-ray structures [44], various inhibitors competing with the ATP substrate and exhibiting different selectivity profiles [42] towards the 518 human protein kinases have been designed, and some of them have reached the market as anti-cancer drugs [45]. The gene discussed is WEE1; the disease is cancer.